Kane Biotech Inc. Stock: price and insider trades · Canada
Kane Biotech Inc.: what insiders have been doing
Every trade that managers of Kane Biotech Inc. disclose to SEDI is tracked on this page. The company sits in the Health Care sector. Between 24 October 2025 and 24 October 2026, 7 insiders published 18 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
With 18 filings in twelve months, the company is more active than the median of 14 filings across the 2,734 companies we follow on the same exchange. Looking back to 2016, when coverage begins, insiders filed 28 purchases and 6 sales.
Insider buying of Kane Biotech Inc. has been absent for the past year. Typically, a trade is published a median of 23 days after it takes place. Until a filing is published, the market cannot know about the trade.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- NotesTSXSEDI:4793395
- 500,000 shares@ CA$0.05100.0% of flowOptionsTSXSEDI:4746382
- OptionsTSXSEDI:4746327
- 4,000,000 shares@ CA$0.05100.0% of flowOptionsTSXSEDI:4728297
- OptionsTSXSEDI:4728289
- 1,500,000 sharesOptionsTSXSEDI:4727859
- OptionsTSXSEDI:4727858
- 62,500 sharesWarrantsTSXSEDI:4726092
- 500,000 shares@ CA$0.05100.0% of flowOptionsTSXSEDI:4726036
- OptionsTSXSEDI:4726028
- 1,750,000 sharesOptionsTSXSEDI:4725989
- 500,000 shares@ CA$0.05100.0% of flowOptionsTSXSEDI:4725820
- OptionsTSXSEDI:4725819
- @ €0.0627Convertible DebenturesTSXSEDI:4724819
- Convertible DebenturesTSXSEDI:4724814
- 20,000,000 shares@ CA$0.0654.5% of flowWarrantsTSXSEDI:4724813
- 20,000,000 shares@ CA$0.0545.5% of flowCommon SharesTSXSEDI:4724810
- 14,000,000 shares@ CA$0.0521.5% of flowCommon SharesTSXSEDI:4624724
- 10,000,000 shares@ CA$0.1018.9% of flowCommon SharesTSXSEDI:4506831
- 2,000,000 shares@ CA$0.1048.2% of flowCommon SharesTSXSEDI:4441024Canonical exit: 17 Apr 2025 (T+90)
- 60,000 shares@ CA$0.103.2% of flowCommon SharesTSXSEDI:4440768
- 100,000 shares@ CA$0.1022.4% of flowCommon SharesTSXSEDI:4439069
- 1,000,000 shares@ CA$0.102.0% of flowCommon SharesTSXSEDI:4439070
- Common SharesTSXSEDI:4376357
- 90,000 shares@ CA$0.12564.9% of flowCommon SharesTSXSEDI:4376359Canonical exit: 12 Dec 2024 (T+90)
25 of 90 declarations
About Kane Biotech Inc.
Kane Biotech Inc. is a biotechnology company focused on developing solutions to prevent and treat infections caused by biofilms. It is listed on the XTSE.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
